CYTEK BIOSCIENCES INC (CTKB)
US23285D1090 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 128M 37.93% | 164M 28.13% | 193.015M 17.69% | 208.8M 8.18% | 232.08M 11.15% | 259.37M 11.76% | |
| EBITDA YoY % growth | 10.64M -25.59% | 690K -93.52% | -21.797M -3,258.99% | 23.142M 206.17% | 37.383M 61.54% | 44.631M 19.39% | |
| EBIT YoY % growth | 9.4M -31.39% | -1.8M -119.15% | -27.845M -1,446.94% | -20.788M 25.34% | -8.219M 60.47% | 3.428M 141.71% | |
| Operating Margin | 7.34% | -1.10% | -14.43% | -9.96% | -3.54% | 1.32% | |
| EPS YoY % growth | N/A | 0.14 27.68% | 0.05 -65.00% | -0.06 -224.90% | 0.06 196.67% | 0.09 46.55% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.06 42.80% | -0.02 54.10% | -0.01 93.62% | 0.01 27.50% | 0.06 7.14% | -0.03 -33.33% | -0.02 -200.00% | 0.02 20.00% | 0.07 8.33% |
| Revenue Q2Q % growth | 62.716M 7.70% | 50.105M 11.69% | 55.127M 18.26% | 58.577M 13.74% | 69.912M 11.47% | 56.88M 13.52% | 60.564M 9.86% | 65.048M 11.05% | 80.242M 14.78% |
| EBITDA Q2Q % growth | 16.571M 180.34% | 5.478M 160.63% | 7.736M 254.10% | 8.211M 639.73% | 15.28M -7.79% | 2.846M -48.05% | 4.967M -35.79% | 8.61M 4.86% | 18.142M 18.73% |
| EBIT Q2Q % growth | 3.432M 2,605.11% | -6.495M 39.49% | -3.965M 53.50% | -1.861M 56.19% | 4.275M 24.56% | -7.95M -22.40% | -5.513M -39.04% | -937.38K 49.63% | 7.807M 82.62% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.01 1,100.00% | -0.02 | 0.03 | 165.36% |
| Q2 2024 Q2Q % growth | -0.08 -900.00% | -0.03 | -0.05 | -161.44% |
| Q1 2024 Q2Q % growth | -0.05 | -0.04 | -0.01 | -22.55% |
| Q4 2023 Q2Q % growth | 0.04 -33.33% | 0.00 | 0.04 | 1,077.65% |
| Q3 2023 Q2Q % growth | 0.00 -102.50% | 0.03 | -0.03 | -103.27% |
| Q2 2023 Q2Q % growth | 0.01 -66.67% | 0.03 | -0.02 | -67.32% |
| Q1 2023 Q2Q % growth | 0.00 -100.00% | 0.03 | -0.03 | -100.00% |
| Q4 2022 Q2Q % growth | 0.06 100.00% | 0.05 | 0.01 | 26.04% |
| Q3 2022 Q2Q % growth | 0.04 100.00% | 0.02 | 0.02 | 96.08% |
| Q2 2022 Q2Q % growth | 0.03 | 0.02 | 0.01 | 76.44% |
| Q1 2022 Q2Q % growth | 0.01 | -0.01 | 0.02 | 296.08% |
| Q4 2021 Q2Q % growth | 0.03 | 0.03 | 0.00 | 17.65% |
| Q3 2021 Q2Q % growth | 0.02 | 0.02 | 0.00 | -15.95% |
| Q2 2021 Q2Q % growth | 0.00 | 0.02 | -0.02 | -100.00% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 51.5M 7.29% | 51.71M | -210K | -0.41% |
| Q2 2024 Q2Q % growth | 46.617M -6.19% | 50.517M | -3.9M | -7.72% |
| Q1 2024 Q2Q % growth | 44.86M 20.96% | 44.458M | 402K | 0.90% |
| Q4 2023 Q2Q % growth | 58.233M 20.47% | 57.714M | 519K | 0.90% |
| Q3 2023 Q2Q % growth | 48M 18.58% | 56.585M | -8.585M | -15.17% |
| Q2 2023 Q2Q % growth | 49.693M 23.74% | 46.627M | 3.066M | 6.58% |
| Q1 2023 Q2Q % growth | 37.088M 5.78% | 48.089M | -11.001M | -22.88% |
| Q4 2022 Q2Q % growth | 48.34M 24.30% | 51.225M | -2.885M | -5.63% |
| Q3 2022 Q2Q % growth | 40.48M 17.74% | 44.154M | -3.674M | -8.32% |
| Q2 2022 Q2Q % growth | 40.16M 32.06% | 40.422M | -262K | -0.65% |
| Q1 2022 Q2Q % growth | 35.06M 44.46% | 33.158M | 1.902M | 5.74% |
| Q4 2021 Q2Q % growth | 38.89M | 37.148M | 1.742M | 4.69% |
| Q3 2021 Q2Q % growth | 34.38M | 34.053M | 327K | 0.96% |
| Q2 2021 Q2Q % growth | 30.41M | 28.846M | 1.564M | 5.42% |
| Q1 2021 Q2Q % growth | 24.27M 34.91% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -100% | -500% | 0% | 28.57% |
| Revenue | 0% | -3.02% | 0% | 0.22% |